Best Peptides for Gut Health

BPC-157 has been studied across the widest range of gut problems. It comes from a protective protein in human stomach juice, it stays stable in that juice instead of breaking down, and in rats it healed stomach ulcers whether it was swallowed or injected. The other two gut peptides women ask about are KPV, which has only been tested in mice, and larazotide, which is being studied for celiac disease. Only larazotide has reached phase III trials, and only for celiac disease, so the right pick depends on what is going on in your gut.

Which peptide has the most research for gut health?

BPC-157 holds up in human stomach juice, which most peptides don't. Under the code name PL 14736, it has reached phase II clinical testing for inflammatory bowel disease (BPC-157 and ulcerative colitis review). In the rat ulcer study, researchers compared it with famotidine, a standard ulcer drug. At the top injected dose, BPC-157 beat famotidine in all three ulcer models: 65.5%, 65.6% and 59.9% for BPC-157, against 60.8%, 57.2% and 34.3% for famotidine.

BPC-157 has been studied across the widest range of gut problems of the three: ulcers, gut lining repair and inflammatory bowel disease. That makes it the one to ask about if you want a calmer, better-healed gut. No study has compared the three peptides head to head.

Which gut peptide fits what I'm dealing with?

If you have a diagnosis such as ulcerative colitis, bring it to your clinical team along with your full medication list. If bloating is what bothers you most, tell them exactly what your symptoms are and how long you have had them. Our clinical team can prescribe BPC-157 if it fits your goal.

Should I take BPC-157 as a capsule or an injection for my gut?

Both forms healed ulcers in the rat study, but the injected form did it at a lower dose. In rats, 200 ng/kg injected worked as well as 400 ng/kg delivered into the stomach (rat ulcer study).

A capsule still makes sense for a gut goal. BPC-157 stays stable in human stomach juice instead of breaking down like most peptides, and a review says it may work in both the upper and lower gut (BPC-157 review). Swallowing it sends it straight to the area you want to treat.

The two forms also cost different amounts. One online prescriber, bpc-157.co, lists BPC-157 capsules at $133 to $142 a month. Its injectable costs $197 a month on a 12-month plan, $208 a month on 6 months and $223 a month on 3 months, with $249 a month shown as the full price.

A capsule means no needles. An injection got more effect per dose in rats. Your clinical team chooses the form and dose with you.

Is BPC-157 safe to take?

Only three small human studies have been published on BPC-157, and none of them reported side effects. Large trials have not been done yet.

FDA says compounded BPC-157 may trigger an immune reaction when given by some routes. FDA also says it can be hard to make free of peptide impurities and has too little safety information for FDA to know whether it would cause harm. Where your vial or capsules come from matters.

BPC-157 encourages new blood vessel growth. Tumors use that same process to grow, so researchers have raised a theoretical concern about cancer. Tell your clinical team about any cancer history.

If you compete in a drug-tested sport, note that WADA, the World Anti-Doping Agency, has banned BPC-157 both in competition and in training since 2022.

Where does FDA stand on BPC-157 right now?

In September 2023, FDA placed BPC-157 in Category 2. That is FDA's group of compounding ingredients that raise significant safety concerns, and FDA cited safety, impurities and too little human data.

FDA's compounding safety page now lists the BPC-157 nomination as withdrawn, and FDA kept its risk note beside it. A withdrawn nomination does not mean FDA found BPC-157 safe.

On July 23, 2026, FDA's Pharmacy Compounding Advisory Committee met to discuss adding BPC-157 to the list of ingredients compounding pharmacies can use. Ulcerative colitis was the use under review (FDA meeting page). Advisory committees make recommendations. FDA makes the decision.

Take the quiz so our clinical team can see whether BPC-157 fits your gut goal, and whether a capsule or an injection suits you better.